Skip to main content

Peer Review reports

From: Ammidin ameliorates myocardial hypoxia/reoxygenation injury by inhibiting the ACSL4/AMPK/mTOR-mediated ferroptosis pathway

Original Submission
10 Feb 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Mar 2023 Reviewed Reviewer Report
11 Apr 2023 Reviewed Reviewer Report - Babak Pakbin
10 Jun 2023 Author responded Author comments - Jian Sun
Resubmission - Version 3
10 Jun 2023 Submitted Manuscript version 3
30 Jul 2023 Author responded Author comments - Jian Sun
Resubmission - Version 4
30 Jul 2023 Submitted Manuscript version 4
19 Sep 2023 Author responded Author comments - Jian Sun
Resubmission - Version 5
19 Sep 2023 Submitted Manuscript version 5
11 Oct 2023 Reviewed Reviewer Report
30 Oct 2023 Reviewed Reviewer Report - Babak Pakbin
15 Nov 2023 Author responded Author comments - Jian Sun
Resubmission - Version 6
15 Nov 2023 Submitted Manuscript version 6
21 Nov 2023 Author responded Author comments - Jian Sun
Resubmission - Version 7
21 Nov 2023 Submitted Manuscript version 7
22 Nov 2023 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
30 Nov 2023 Editorially accepted
15 Dec 2023 Article published 10.1186/s12906-023-04289-x

You can find further information about peer review here.

Back to article page